Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05011552 · ClinicalTrials.gov registry record · NA
Feasibility Study for Abused Chinese Immigrant Women
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05011552 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 50 participants.
The verdict
NCT05011552, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Intimate partner violence (IPV) is a serious social and public health issue. In the U.S., more than 1 in 3 women experience physical or sexual violence, and/or stalking by an intimate partner during their lifetime. IPV has significant physical and mental health consequences such as injury, chronic pain, and depression. Chinese immigrants have been overlooked and underserved and represent an especially vulnerable group of IPV victims, as they are less likely to seek help through IPV service agencies, women's shelters, hospitals, or law enforcement. Effective IPV intervention programs that are culturally appropriate, accessible, and acceptable are essential to this underserved population. However, no studies have been conducted with abused Chinese immigrant women to help them deal with IPV and reduce mental health consequences. Therefore, the study adapted a structured IPV intervention from the Domestic Violence Enhanced Home Visitation Program (DOVE) as well as incorporate self-compassion and relaxation techniques for Chinese immigrant women experiencing IPV. The intervention is called Self-Compassion, Health, and Empowerment (SHE). The study will test the feasibility and acceptability of the SHE to reduce IPV and improve mental health well-being for abused Chinese immigrant women residing in the US.
Interventions
- BEHAVIORAL Self-Compassion, Health, and Empowerment (SHE)
- BEHAVIORAL The Control Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2023-03-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05011552
The ClinicalTrials.gov registry entry for NCT05011552 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Self-Compassion, Health, and Empowerment (SHE) is the first listed.
NCT05011552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05011552 about?
NCT05011552 is a clinical study titled "Feasibility Study for Abused Chinese Immigrant Women". Intimate partner violence (IPV) is a serious social and public health issue. In the U.S., more than 1 in 3 women experience physical or sexual violence, and/or stalking by an intimate partner during their lifetime. IPV has significant physical and mental health consequences such as injury, chronic p...
What is the current status of trial NCT05011552?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-03-01. Estimated completion is 2023-03-03.
What interventions are being tested in trial NCT05011552?
The interventions under investigation include: Self-Compassion, Health, and Empowerment (SHE) (BEHAVIORAL), The Control Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT05011552?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.